FDA Warning Letter — Bingbing Pharmaceutical (Hubei) Co., Ltd
The FDA took a Warning Letter action against Bingbing Pharmaceutical (Hubei) Co., Ltd on Oct 3, 2019 (Shiyan, China). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Bingbing Pharmaceutical (Hubei) Co., Ltd
- Date
- Oct 3, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Shiyan (China)